Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Neuropilin 1 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement Neuropilin 1 dans ELISA (Capture) et ELISPOT (Capture). Il présente une réactivité envers Humain.
N° du produit ABIN2664540

Aperçu rapide pour Neuropilin 1 anticorps (ABIN2664540)

Antigène

Voir toutes Neuropilin 1 (NRP1) Anticorps
Neuropilin 1 (NRP1)

Reactivité

  • 115
  • 59
  • 52
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 103
  • 36
  • 6
  • 4
  • 1
Souris

Clonalité

  • 97
  • 53
Monoclonal

Conjugué

  • 67
  • 20
  • 15
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Neuropilin 1 est non-conjugé

Application

  • 103
  • 44
  • 35
  • 35
  • 23
  • 20
  • 15
  • 14
  • 11
  • 10
  • 4
  • 4
  • 2
  • 1
  • 1
ELISA (Capture), ELISpot (Capture) (ELISPOT (Capture))

Clone

12C2
  • Purification

    The antibody was purified by affinity chromatography.

    Isotype

    IgG2a kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Antigène

    Neuropilin 1 (NRP1)

    Autre désignation

    CD304

    Sujet

    CD304, also known as neuropilin-1, BDCA-4 and VEGF165R, is a 140 kD type I transmembrane protein. Its extracellular region contains two CUB, two FV/FVIII, and one MAM domain, a soluble isoform is produced by alternative mRNA splicing. CD304 is involved in angiogenesis, neural development, and tumor metastasis. It is expressed by plasmacytoid dendritic cells, thymocytes, neurons, endothelium, and a subset of TFH cells. CD304 is also expressed in several carcinomas, and a high expression of this molecule in prostate cancer correlates with a poor prognosis.

    Pathways

    Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, Smooth Muscle Cell Migration, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals
Vous êtes ici:
Chat with us!